Scarica l'app Stockscreener
2.43
2.02%
-0.05
Dopo l'orario di chiusura:
2.44
0.010
+0.41%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ERAS Giù?
Forum
Previsione
Precedente Chiudi:
$2.48
Aprire:
$2.52
Volume 24 ore:
4.90M
Relative Volume:
3.77
Capitalizzazione di mercato:
$689.32M
Reddito:
-
Utile/perdita netta:
$-125.04M
Rapporto P/E:
-2.9634
EPS:
-0.82
Flusso di cassa netto:
$-122.99M
1 W Prestazione:
+9.95%
1M Prestazione:
+56.77%
6M Prestazione:
+129.25%
1 anno Prestazione:
-3.57%
Intervallo 1D:
$2.41
$2.765
Intervallo di 1 settimana:
$2.125
$2.765
Portata 52W:
$1.01
$3.305
Erasca Inc Stock (ERAS) Company Profile
Nome
Erasca Inc
Settore
Industria
Telefono
(858) 465-6511
Indirizzo
3115 MERRYFIELD ROW, SAN DIEGO
Confronta ERAS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ERAS
Erasca Inc
|
2.43 | 703.50M | 0 | -125.04M | -122.99M | -0.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.15 | 105.19B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
450.68 | 60.24B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.86 | 61.82B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
798.94 | 49.09B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
351.09 | 37.52B | 4.56B | -176.77M | 225.30M | -1.7177 |
Erasca Inc Stock (ERAS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-03 | Downgrade | BofA Securities | Buy → Underperform |
| 2025-08-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-26 | Iniziato | Raymond James | Outperform |
| 2024-11-18 | Iniziato | Jefferies | Buy |
| 2024-03-11 | Iniziato | CapitalOne | Overweight |
| 2024-01-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-10-11 | Iniziato | H.C. Wainwright | Buy |
| 2023-03-30 | Iniziato | Mizuho | Buy |
| 2023-02-24 | Iniziato | Goldman | Buy |
| 2023-02-03 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
Mostra tutto
Erasca Inc Borsa (ERAS) Ultime notizie
Will Erasca Inc. price bounce be sustainableIndex Update & Accurate Entry/Exit Alerts - newser.com
Why Erasca Inc. stock remains on buy lists2025 Year in Review & Fast Gain Stock Trading Tips - newser.com
Will Erasca Inc. stock benefit from upcoming earnings reportsJuly 2025 Short Interest & Low Risk High Reward Ideas - newser.com
Can swing trading help recover from Erasca Inc. losses2025 Price Momentum & Community Driven Trade Alerts - newser.com
Why retail investors favor Erasca Inc. stockMarket Performance Summary & Weekly High Conviction Ideas - newser.com
Erasca: Hype Building Into The End Of The Year (Rating Downgrade) (NASDAQ:ERAS) - Seeking Alpha
Fidus Investment, Rocket Companies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
Why Concorde International Group Shares Are Trading Higher By 55%; Here Are 20 Stocks Moving Premarket - Benzinga
What drives Erasca Inc stock priceMarket Rumors and News & High Return Stock Ideas - earlytimes.in
Erasca Inc Stock Analysis and ForecastBreakout Stock Watch & Interactive Charts for Smarter Trading - earlytimes.in
Erasca, Inc. (NASDAQ:ERAS) Receives $3.71 Consensus PT from Analysts - Defense World
Key resistance and support levels for Erasca Inc.Weekly Profit Summary & AI Driven Stock Price Forecasts - newser.com
Wall Street Zen Upgrades Erasca (NASDAQ:ERAS) to Hold - Defense World
Erasca Inc Azioni (ERAS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.05%
4.71%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):